NASHVILLE, Tenn. (WKRN) – A vaccine being tested in Nashville is showing promise in fighting a virus often associated with serious illness in young children and older adults.
Respiratory Syncytial Virus, commonly known as RSV, sends about 177,000 older adults to the hospital each year. Now, a Pfizer vaccine being tested in Nashville, is reporting 85% effectiveness in fighting RSV among older adults.
